Technology Advancement: Hybrid Closed-Loop Insulin Pump

American Association of Diabetes Educators. Continuous subcutaneous insulin infusion (CSII) without and with sensor integration. https://www.diabeteseducator.org/docs/default-source/default-document-library/continuous-subcutaneous-insulin-infusion-2018-v2.pdf?sfvrsn=0. Accessed July 5, 2018.

Automated insulin delivery. https://diatribe.org/automated-insulin-delivery. Accessed December 7, 2017.

Bergenstal RM Garg S Weinzimer SA et al . Safety of a hybrid closed-loop insulin delivery system in patients with type 1 diabetes. JAMA. 2016;316:1407-1408.

Fonseca VA Grunberger G Anhalt H et al . Continuous glucose monitoring: a consensus conference of the American Association of Clinical Endocrinologists and American College of Endocrinology. Endocr Pract. 2016;22:1008-1021.

Food and Drug administration. FDA advisory panel votes to recommend non-adjunctive use of Dexcom G5 mobile CGM. Diab Tech Ther. 2016;18:512-516.

Lilly developing smart pens and automated insulin delivery pump. https://diatribe.org/lilly-developing-smart-pens-and-automated-insulin-delivery-pump. Accessed December 7, 2017.

MiniMed™ 670G system user guide. https://www.medtronicdiabetes.com/download-library/MiniMed-670g-system. Accessed September 5, 2017.

National Institutes of Health. https://www.nih.gov/news-events/news-releases/four-pivotal-nih-funded-artificial-pancreas-research-efforts-begin. Accessed September 5, 2017.

Premarket approvals/Abbott Freestyle Flash. https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpma/pma.cfm?id=P160030s008. Accessed December 7, 2017.

Tanenbaum ML Adams RN Hanes SJ et al . Optimal use of diabetes devices: clinician perspectives on barriers and adherence to device use. J Diabetes Sci Technol. 2017;11: 484-492.

Why do some people with T1D stop using a pump and CGM? https://t1dexchange.org/pages/why-do-some-people-with-t1d-stop-using-a-pump-and-cgm/. Accessed September 5, 2017.